InspireMD (NSPR) Income from Continuing Operations (2010 - 2025)
InspireMD (NSPR) reported Income from Continuing Operations of 27298000.0 for Q4 2025, up 56.64% on a YoY basis from 17427000.0 in Q4 2024, and up 309.16% quarter-over-quarter from 13051000.0 in Q3 2025.
InspireMD (NSPR) Income from Continuing Operations (2010 - 2025) Analysis & Trends
InspireMD has reported Income from Continuing Operations for 16 years, with the latest figure at 27298000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations rose 56.64% year-over-year to 27298000.0; the trailing twelve-month figure through Dec 2025 stood at 10232000.0 (down 52.51% YoY), and the FY2025 full-year result was 48786000.0, down 52.43% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 27298000.0, up from 13051000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 27298000.0 in Q4 2025, with the low at 13051000.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 3571000.0 across 5 years, with a median of 4726500.0 in 2022.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations sank 85.47% — and 2024, when it surged 400.05%.
- InspireMD's Income from Continuing Operations stood at 4052000.0 in 2021, then declined by 18.88% to 4817000.0 in 2022, then retreated by 20.57% to 5808000.0 in 2023, then surged by 400.05% to 17427000.0 in 2024, then surged by 56.64% to 27298000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 27298000.0 (Q4 2025), 13051000.0 (Q3 2025), and 13019000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | 27.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.30 Mn |
| Sep 30, 2025 | -13.05 Mn |
| Jun 30, 2025 | -13.02 Mn |
| Mar 31, 2025 | -11.46 Mn |
| Dec 31, 2024 | 17.43 Mn |
| Sep 30, 2024 | -8.46 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -7.41 Mn |
| Dec 31, 2023 | -5.81 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.32 Mn |
| Mar 31, 2023 | -4.38 Mn |
| Dec 31, 2022 | -4.82 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.48 Mn |
| Dec 31, 2021 | -4.05 Mn |
| Sep 30, 2021 | -4.07 Mn |
| Jun 30, 2021 | -3.51 Mn |
| Mar 31, 2021 | -3.24 Mn |